Cramer’s week ahead: FedEx’s warning shows the Fed is further along in fighting inflation than expected

Cramer’s week ahead: FedEx’s warning shows the Fed is further along in fighting inflation than expected


Cramer's week ahead: FedEx's warning shows the Fed is further along in inflation battle than expected

CNBC’s Jim Cramer on Friday said that FedEx’s warning of worsening economic conditions suggests the Federal Reserve is doing better in its inflation effort than expected — meaning the central bank could take a step back after its meeting next week.

“If Fed chief Jay Powell watched our interview last night … he might discover that he’s made more progress whipping inflation than he might realize,” Cramer said.

“Maybe Powell will hit us with another 75 basis point hike right here and then say maybe it’s time to take a more measured approach in order to assess how things are going,” he added.

The “Mad Money” host’s comments came after FedEx, a bellwether company for the state of the economy, warned on Thursday of a decline in global shipments and an impending world recession.

Stocks closed down on Friday as Wall Street digested the news, with the major averages recording their fourth losing week in the past five weeks.

Cramer also previewed next week’s slate of earnings. All earnings and revenue estimates are courtesy of FactSet.

Monday: AutoZone

  • Q4 2022 earnings release at 6:55 a.m. ET; conference call at 10 a.m. ET
  • Projected EPS: $38.5
  • Projected revenue: $5.16 billion

Cramer said he’s interested in knowing if company officials see an end to the car shortage.

Tuesday: Nvidia

  • GTC Financial Analyst Q&A at 1 p.m. ET

Cramer said he’s sticking with Nvidia despite the stock’s recent tumbles. “That’s how Nvidia behaves — you get terrifyingly swift moves down followed by long rallies.”

Wednesday: General Mills, Salesforce, Lennar, KB Homes

General Mills

  • Q1 2023 earnings release at 7 a.m. ET; conference call at 9 a.m. ET
  • Projected EPS: $1
  • Projected revenue: $4.72 billion

The company will likely be a winner because it’s a best-of-breed food stock in an uncertain economic environment, Cramer predicted.

Salesforce

  • Investor Day at 4 p.m. ET 

Cramer said that while he doesn’t expect to hear anything that could motivate him to buy the stock, he’s still bullish long term.

Lennar

  • Q3 2022 earnings release at 4:30 p.m. ET; conference call on Thursday at 11 a.m. ET
  • Projected EPS: $4.86
  • Projected revenue: $8.97 billion

KB Home

  • Q3 2022 earnings release between 4:10 to 4:20 p.m. ET; conference call at 5 p.m. ET
  • Projected EPS: $2.66
  • Projected revenue: $1.88 billion

Cramer said he expects both Lennar and KB Home to be soft due to soaring mortgage rates.

Thursday: Costco, FedEx, Qualcomm

Costco

  • Q4 2022 earnings release at 4:15 p.m. ET; conference call at 5 p.m. ET
  • Projected EPS: $4.17
  • Projected revenue: $70.8 billion

Cramer said he hopes the stock goes down so that the Investing Club can buy more.

FedEx

While the company could reveal more information on its latest quarter, its trajectory likely won’t change since it already reported disappointing results in its preliminary announcement, Cramer said.

Qualcomm

  • Automotive Investor Day at 3 p.m. ET

Cramer said that the company will show off the “new Qualcomm” during the event.

Disclaimer: Cramer’s Charitable Trust owns shares of Costco, Salesforce, Nvidia and Qualcomm.

Cramer's game plan for the trading week of Sept. 19

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More